Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DUT | P33316 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28262007 | 0.98 | DUT (0.41) | DUT | |
| SCHEMBL11580466 | 0.83 | DUT (0.42) | DUT | |
| SCHEMBL32434539 | 0.79 | DUT (0.42) | DUT | |
| SCHEMBL95573 | 0.78 | DUT (0.34) | DUT | |
| SCHEMBL132024 | 0.78 | — | — | |
| SCHEMBL26510570 | 0.77 | DUT (0.41) | DUT | |
| SCHEMBL20088142 | 0.77 | DUT (0.41) | DUT | |
| SCHEMBL17739984 | 0.77 | DUT (0.39) | DUT | |
| SCHEMBL28000694 | 0.76 | DUT (0.33) | DUT | |
| SCHEMBL25373236 | 0.76 | DUT (0.41) | DUT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112442011-B | Prodrug compound and application thereof in treating cancers | 润佳（苏州）医药科技有限公司 | 2023-11-14 | — | — | CN | disclosed |
| EP-4021912-A1 | PRODRUGS OF THE TYROSINE KINASE INHIBITOR FOR TREATING CANCER | Risen (Suzhou) Pharma Tech Co., Ltd. (CN) | 2022-07-06 | — | — | EP | disclosed |
| CN-112442011-A | Prodrug compound and application thereof in treating cancer | 润佳（苏州）医药科技有限公司 | 2021-03-05 | — | — | CN | disclosed |
| WO-2021035360-A1 | PRODRUGS OF THE TYROSINE KINASE INHIBITOR FOR TREATING CANCER | Risen (Suzhou) Pharma Tech Co., Ltd. (CN) | 2021-03-04 | — | — | WO | disclosed |
| CN-106470708-B | Antibody-drug-conjugates and their use for the treatment of cancer | 皮埃尔法布雷医药公司 | 2019-12-31 | — | — | CN | disclosed |
| US-6440990-B1 | O-alkylated rapamycin derivatives and their use, particularly as immunosuppressants | NOVARTIS AG (CH) | 2002-08-27 | — | — | US | disclosed |